Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 2
Submit an article Journal homepage
56
Views
8
CrossRef citations to date
0
Altmetric
Research Article

In Vitro Drug Resistance Profiles of Adult Acute Lymphoblastic Leukemia: Possible Explanation for Difference in Outcome to Similar Therapeutic Regimens

Jan Styczynski Department of Pediatric Hematology and Oncology, Medical University, ul. Chodkiewicza 44, 85-667 Bydgoszcz, Poland
&
Mariusz Wysocki Department of Pediatric Hematology and Oncology, Medical University, ul. Chodkiewicza 44, 85-667 Bydgoszcz, Poland
Pages 301-307 | Published online: 01 Jul 2009

  • O'Connor, O.A. and Weiss, M. (1999) "Recent advances in the biology and management of acute lymphoblastic leukaemia in adults", In: Tallman, M.S. and Gordon, L.I., eds, Diagnostic and Therapeutic Advances in Hematologic Malignancies (Kluwer Academic Publishers, Boston), pp 307-333.
  • Chessels, J.M., Hall, E., Prentice, H.G., Durrant, J., Bailey, C.C. and Richards, S.M. (1998) "The impact of age on outcome in lymphoblastic leukaemia: MRC UKALL X and XA compared: a report from the MRC paediatric and adult working parties", Leukemia 12, 463-473.
  • Durrant, I.J., Richards, S.M., Prentice, H.G. and Goldstone, A.H. (2000) "The Medical research trials in adult acute lymphoblastic leukemia", Hematology-Oncology Clinics of North America 14, 1327-1353.
  • Hoelzer, D. and Gokbuget, N. (2000) "New approaches to acute lymphoblastic leukemia in adults: where do we go?", Seminars in Oncology 27, 540-559.
  • Pui, C.H. and Evans, W.E. (1998) "Acute lymphoblastic leukemia", The New England Journal of Medicine 339, 605-615.
  • Legrand, O., Marie, J.P., Marjanovic, Z., Cadiou, M., Blanc, C., Ramond, S., Viguie, F., Perrot, J.Y. and Zittoun, R. (1997) "Prognostic factors in elderly acute lymphoblastic leukaemia", British Journal of Haematology 97, 596-602.
  • Cortes, J.E. and Kantarijan, H.M. (1995) "Acute lymphoblastic leukemia: a comprehensive review with emphasis on biology and therapy", Cancer 76, 2393-2417.
  • Copelan, E.A. and McGuire, E.A. (1995) "The biology and treatment of acute lymphoblastic leukemia in adults", Blood 85, 1151-1168.
  • Perentesis, J.P. (1997) "Why is age such an important independent prognostic factor in acute lymphoblastic leukemia?", Leukemia 11(Suppl. 4), s4-s7.
  • Larson, R.A., Stock, W., Hoelzer, D.F. and Kantarijan, H. (1998) "Acute lymphoblastic leukemia in adults", Hematology, The American Society of Hematology Education Program Book, pp 45-62.
  • Czuczman, M.S., Dodge, R.K., Stewart, C.C., Frankel, S.R., Davey, F.R., Powell, B.L., Szatrowski, T.P., Schiffer, C.A., Larson, R.A. and Bloomfield, C.D. (1999) "Value of immunophenotype in intensively treated adult acute lymphoblastic leukaemia: Cancer and Leukemia Group B Study 8364", Blood 93, 3931-3939.
  • Schrappe, M., Reiter, A., Zimmerman, M., Harbott, J., Ludwig, W.D., Henze, G., Gadner, H., Odenwald, E. and Riehm, H. (2000) "Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995", Leukemia 14, 2205-2222.
  • Appelbaum, F.R. (1999) "Molecular diagnosis and clinical decisions in adult acute leukemia", Seiinars in Hematology 36, 401-410.
  • Ferrando, A.F. and Look,A.T. (2000) Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lyMphoblastic leukaemia", Seminars in Hematology 37, 381-395.
  • Ramakers-van Woerden, N.L., Pieters, R., Kaspers, G.J.L., Loonen, A.H., Van Zantwijk, C.H., Ludwig, W.D. and Veerman, A.J.P. (1997) "The Philadelphia chromosome t(9;22) is associated with in vitro prednisolone and daunorubicin resistance in adult acute lymphoblastic leukaemia", Annals of Hematology 74, A38, (abstract).
  • Kuittinen, O., Savolainen, E.R., Koistinen, P., Mottonen, M. anD Turpeenniemi-HUjanen, T. (2001) "MMP-2 and MMP-9 expression in adult and childhood acute lymphoblastic leukemia (ALL)", Leukemia Research 25, 125-132.
  • Hoelzer, D. (1998) "Overview of chemotherapy for ALL", Leukemia and Lymphoma 30(Suppl. 1), 41-44.
  • Seeker-Walker, L.M., Craig, J.M., Hawkins, J.M. and Hoffbrand, A.V. (1991) "Philadelphia positive acute lymphoblastic leukaemia in adults: age distribution, BCR breakpoint and prognostic significance", Leukemia 5, 196-199.
  • Nygren, P., Kristensen, J., Jonsson, B., Sundstrom, C., Lonnerholm, G., Kreuger, A. and Larsson, R. (1992) "Feasibility of the fluorometric microculture cytotoxicity assay (FMCA) for cytotoxic drug sensitivity testing of tumor cells from patients with acute lymphoblastic leukemia", Leukemia 6, 1121-1128.
  • Maung, Z.T., Reid, M.M., Mathcson, E., Taylor, P.R., Proctor, S.J. and Hall, A.G. (1995) "Corticosteroid resistance is increased in lymphoblasts from adults compared with children: preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukaemia", British Journal of Haematology 91, 93-100.
  • Styczynski, J., Pieters, R., Huismans, D.R., Schuurhuis, G.J., Wysocki, M. and Veerman, A.J.P. (2000) "In vitro drug resistance profiles in adult versus childhood acute lymphoblastic leukaemia", British Journal of Haematology 110, 813-818.
  • Zwaan, C.M., Kaspers, G.J.L., Pieters, R., Loonen, A.H., Wunsche, R., Wondergem, M.J., De Haas, T.G.K.J., Creutzig, U., Bartl, S., Hahlen, K., Ossenkoppele, G.J. and Veerman, A.J.P. (1998) "No clinically significant differences in in vitro drug resistance between childhood and adult ANLL", Blood 92(10 Suppl. 1), 198b, (AHS, abstract 3843).
  • Weiss, M.A. (1997) 'Treatment of adult patients with relapsed or refractory acute lymphoblastic leukemia (ALL)", Leukemia 11(Suppl. 4), s28-s30.
  • Styczynski, J., Pieters, R., Huismans, D.R., Schuurhuis, G.J., Veerman, A.J.P. and Wysocki, M. (1999) "Comparison of cellular drug resistance in acute lymphoblastic leukemia in children and in adults", Acta Haematologica Polonica 30, 283-290.
  • Pieters, R., Den Boer, M.L., Durian, M., Janka, G., Schmiegelow, K., Kaspers, G.J.L., Van Wering, E.R. and Veerman, A.J.P. (1998) "Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants", Leukemia 12, 1344-1348.
  • Pieters, R., Huismans, D.R., Loonen, A.H., Hählen, K., Van der Does-van den Berg, A., Van Wering, E.R. and Veerman, A.J.P. (1991) "Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia", Lancet 338, 399-403.
  • Kaspers, G.J., Pieters, R., Van Zantwijk, C.H., Van Wering, E.R., Van Der Does-Van Den Berg, A. and Veerman, A.J. (1998) "Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs", Blood 92, 259-266.
  • Kaspers, G.J., Pieters, R., Van Zantwijk, C.H., Van Wering, E.R. and Veerman, A.J. (1995) "Clinical and cell biological features related to cellular drug resistance of childhood acute lymphoblastic leukemia cells", Leukemia and Lymphoma 19, 407-416.
  • Dordelmann, M., Reiter, A., Borkhardt, A., Ludwig, W.D., Gotz, N., Viehmann, S., Gadner, H., Riehm, H. and Schrappe, M. (2000) "Prednisolone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia", Blood 94, 1209-1217.
  • Tosi, P., Visani, G., Ottaviani, E., Manfroi, S. and Tura, S. (1996) "In vitro culture with prednisolone increases BCL-2 protein expression in adult acute lymphoblastic leukemia cells", American Journal of Hematology 51, 261-264.
  • Tosi, P., Visani, G., Ottaviani, E., Manfroi, S. and Tura, S. (1996) "Biological and clinical significance of in vitro prednisolone resistance in adult acute lymphoblastic leukaemia", European Journal of Haematology 57, 134-141.
  • Umeda, Y., Yamauchi, K., Sugawara, I., Arimori, S. and Nagao, T. (1994) "Relationship between expression of P-glycoprotein and use of noncytotoxic drugs before chemotherapy in acute leukemia", Cancer Journal 7, 39-43.
  • Ramakers-Van Woerden, N.L., Pieters, N.L., Loonen, A.H., Hubeek, I., Van Drunen, E., Bema-Beverloo, H., Slater, R.M., Harbott, J., Seyfarth, J., Van Wering, E.R., Hahlen, K., Schmiegelow, K., Janka-Schaub, G.E. and Veerman, A.J.P. (2000) "TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia", Blood 96, 1094-1099.
  • Goker, E., Lin, J.T., Trippett, T., Elisseyeff, Y., Tong, W.P., Niedzwiecki, D., Tan, C., Steinherz, P., Schweitzer, B.I. and Bertino, J.R. (1993) "Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease", Leukemia 7, 1000-1004.
  • Goker, E., Waltham, M., Kheradpour, A., Trippett, T., Mazumdar, M., Elisseyeff, Y., Schnieders, B., Steinherz, P., Tan, C., Berman, E. and Bertino, J.R. (1995) "Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations", Blood 86, 677-684.
  • Sauerbrey, A., Volm, M. and Zintl, F. (1995) "Expression and clinical significance of resistance proteins in initial acute lymphatic leukemia (ALL) in childhood", Klinische Padiatrie 207, 230-234.
  • Kuwazuru, Y., Yoshimura, A., Hanada, S., Utsunomiya, A., Makino, T., Ishibashi, K., Kodama, M., Iwahashi, M., Arima, T. and Akiyama, S. (1990) "Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance", Cancer 66, 868-873.
  • Wattel, E., Lepelley, P., Merlat, A., Sartiaux, C., Bauters, F., Jouet, J.P. and Fenaux, P. (1995) "Expression of the multidrug resistance P-glycoprotein in newly diagnosed adult acute lymphoblastic leukemia: absence of correlation with response to treatment", Leukemia 9, 1870-1874.
  • Kuwazuru, Y., Hanada, S., Furukawa, T., Yoshimura, A., Sumizawa, T., Utsunomiya, A., Ishibashi, K., Saito, T., Uozumi, K., Maruyama, M., Ishizawa, M., Arima, T. and Akiyama, S. (1990) "Expression of P-glycoprotein in adult T-cell leukemia cells", Blood 76, 2065-2071.
  • Goasguen, J.E., Dossot, J.M., Fardel, O., Le-Mee, F., Le-Gall, E., Leblay, R., LePrise, P.Y., Chaperon, J. and Fauchet, R. (1993) "Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de nova acute lymphoblastic leukemia: prognostic implications", Blood 81, 2394-2398.
  • Savignano, C., Geromin, A., Michieli, M., Damiani, D., Michelutti, A., Melli, C., Fanin, R. and Baccarani, M. (1993) "The expression of the multidrug resistance related glycoprotein in adult acute lymphoblastic leukemia", Haematologica 78, 261-263.
  • Kohler, T., Leiblein, S., Borchert, S., Eller, J., Rost, A.K., Lassner, D., Krahl, R., Helbig, W., Wagner, O. and Remke, H. (1999) "Absolute levels of MDR-1, MRP, and BCL-2 MRNA and tumor remission in acute leukemia", Advances in Experimental Medicine and Biology 457, 177-185.
  • Van den Heuvel-Eibrink, M.M., Sonneveld, P. and Pieters, R. (2000) "The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia", International Journal of Clinical Pharmacology and Therapeutics 38, 94-110.
  • Tsuji, K., Moloji, T., Sugawara, I., Shiozaki, H., Wang, Y.H., Motomura, S., Okada, M., Yasunami, T., Sano, F., Takahashi, M., Kawada, H., Maseki, N., Hoshino, S., Ishida, M. and Mizoguchi, H. (2000) "Significance of lung resistance-related protein in the clinical outcome of acute leukaemic patients with reference to P-glycoprotein", British Journal of Haematology 110, 370-378.
  • Hart, S.M., Ganeshaguru, K., Hoffbrand, A.V, Prentice, H.G. and Mehta, A.B. (1994) "Expression of the multidrug resistance-associated protein (MRP) in acute leukaemia", Leukemia 8, 2163-2168.
  • Burger, H., Nooter, K., Zaman, G.J., Sonneveld, P., van Wingerden, K.E., Oostrum, R.G. and Stoter, G. (1994) "Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias", Leukemia 8, 990-997.
  • Ikeda, K., Oka, M., Yamada, Y., Soda, H., Fukuda, M., Kinoshita, A., Tsukamoto, K., Noguchi, Y., Isomoto, H., Takeshima, F., Murase, K., Kamihira, S., Tomonaga, M. and Kohno, S. (1999) "Adult T-cell leukemia cells over-express the multidrug-resistance-protein (MRP) and lung-resistance-protein (MRP) genes", International Journal of Cancer 82, 599-604.
  • Ross, D.R., Karp, J.E., Chen, T.T. and Doyle, L.A. (2000) "Expression of breast cancer resistance protein in blast cells from patients with acute leukemia", Blood 96, 365-368.
  • Valkov, N.I. and Sullivan, D.M. (1997) "Drug resistance to DNA topoisomerase I and II inhibitors in human leukaemia, lymphoma and multiple myeloma", Seminars in Hematology 34(Suppl. 5), 48-62.
  • Beck, J., Handgretinger, R., Dopfer, R, Klingebiel, T., Niethammer, D. and Gekeler, V. (1995) "Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias", British Journal of Haematology 89, 356-363.
  • Beck, J., Niethammer, D. and Gekeler, V. (1996) "MDR1, MRP, topoisomerase II alpha/beta, and cyclin A gene expression in acute and chronic leukemias", Leukemia 10(Suppl. 3), s39-s45.
  • Maung, Z.T., Hogarth, L., Reid, M.M., Proctor, S.J., Hamilton, P.J. and Hall, A.G. (1994) "Raised intracellular glutathione levels correlate with in vitro resistance to cytotoxic drugs in leukaemic cells from patients with acute lymphoblastic leukaemia", Leukemia 8, 1487-1491.
  • Hall, A., Foster, S., Proctor, S.J. and Cattan, A.R. (1990) "Purification and characterization of a pi class glutathione S-transferase from human leukaemic cells", British Journal of Haematology 76, 494-500.
  • Hall, A.G., Autzen, P., Cattan, A.R., Malcolm, A.J., Cole, M., Kernahan, J. and Reid, M.M. (1994) "Expression of mu class glutathione S-transferase correlates with event-free survival in childhood acute lymphoblastic leukemia", Cancer Research 54, 5251-5254.
  • Matheson, E.C. and Hall, A.G. (1999) "Expression of DNA mismatch repair proteins in acute lymphoblastic leukaemia and normal bone marrow", Advances in Experimental Medicine and Biology 457, 579-583.
  • Coulthard, S.A., Howell, C., Robson, J. and Hall, A.G. (1998) "The relationship between thiopurine methyltransferase activity and genotype in blasts from patients with acute leukemia", Blood 92, 2856-2862.
  • Gala, J.L., Vermylen, C., Cornu, G., Ferrant, A., Michaux, J.L., Philippe, M. and Martiat, P. (1994) "High expression of bcl-2 is the rule in acute lymphoblastic leukemia, except in Burkitt subtype at presentation, and is not correlated with the prognosis", Annals of Hematology 69, 17-24.
  • Campos, L., Sabido, O., Sebban, C., Charrin, C., Bertheas, M.F., Ficre, D. and Guyotat, D. (1996) "Expression of BCL-2 protooncogene in adult acute lymphoblastic leukemia", Leukemia 10, 434-438.
  • Coustan-Smith, E., Kitanaka, A., Pui, C.H., McNinch, L., Evans, W.E., Raimondi, S.C., Behm, F.G., Arico, M. and Campana, D. (1996) "Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia", Blood 87, 1140-1146.
  • Maung, Z.T., MacLean, F.R., Reid, M.M., Pearson, A.D.J., Proctor. S.J., Hamilton, P.J. and Hall, A.G. (1994) "The relationship between bcl-2 expression and response to chemotherapy in acute leukaemia", British Journal of Haematology 88, 105-109.
  • Faderl, S., Thall, P.F., Kantarjian, H.M., Talpaz, M., Harris, D., Van, Q., Beran, M., Kornblau, S.M., Pierce, S. and Estrov, Z. (1999) "Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia", Clinical Cancer Research 5,. 4041-4047.
  • Prokop, A., Wieder, T., Sturm, I., Ebmann, F., Seeger, K., Wuchter, C., Ludwig, W.D., Henze, G., Dorken, B. and Daniel, P.T. (2000) "Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo", Leukemia 14, 1606-1613.
  • Stock, W., Tsai, T, Golden, C., Rankin, C., Sher, D., Slovak, M.L., Pallavicini, M.G., Radich, J.P. and Boldt, D.H. (2000) "Cell cycle regulatory gene abnormalities are important determinants of leukemogenesis and disease biology in adult acute lymphoblastic leukemia", Blood 95, 2364-2371.
  • Faderl, S., Kantarjian, H.M., Manshouri, T., Chan, C.Y., Pierce, S., Hays, K.J., Cortes, J., Thomas, D., Estrov, Z. and Albitar, M. (1999) "The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia", Clinical Cancer Research 5, 1855-1861.
  • Tsai, T, Davalath, S., Rankin, C., Radich, J.P., Head, D., Appelbaum, F.R. and Boldt, D.H. (1996) "Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de nova, relapsed, or refractory ALL treated in Southwest Oncology Group studies", Leukemia 10, 1901-1910.
  • Hermine, O., Wattel, E., Gessain, A. and Bazarbachi, A. (1998) "Adult T cell leukaemia: a review of established and new treatments", BioDrugs 10, 447-462.
  • Felix, C.A., Nau, M.M., Takahashi, T., Mitsudomi, T., Chiba, I., Poplack, D.G., Reaman, G.H., Cole, D.E., Letterio, J.J. and WhangPeng, J. (1992) "Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia", Journal of Clinical Investigation 89, 640-647.
  • Zhu, Y.M., Foroni, L., McQuaker, I.G., Papaioannou, M., Haynes, A. and Russell, H.H. (1999) "Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia", British Journal of Cancer 79, 1151-1157.
  • Markaki, E.A., Tsopanomichalou, M., Dimitrou, H., Stiakaki, E., Perdikoyanni, C., Spandidos, D. and Kalmanti, M. (2001) "Mutations of retinoblastoma gene (Rb-1) as a prognostic factor in children with acute leukaemia and neuroblastoma", Pediatric Hematology and Oncology 18, 101-110.
  • King-Underwood, L. and Pritchard-Jones, K. (1998) "Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance", Blood 91, 2961-2968.
  • Gaiger, A., Linnerth, B., Mann, G., Schmid, D., Heinze, G., Tisljar, K., Haas, O.A., Gadner, H. and Lion, T. (1999) "Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol", European Journal of Haematology 63, 86-93.
  • Patmasiriwat, P., Fraizer, G., Kantarjian, H. and Saunders, G.F. (1999) "WT1 and GATA1 expression in myelodysplastic syndrome and acute leukemia", Leukemia 13, 891-900.
  • Gustafsson, B., Stal, O. and Gustafsson, B. (1998) "Overexpression of MDM2 in acute childhood lymphoblastic leukemia", Pediatric Hematology and Oncology 15, 519-526.
  • Zhou, M., Gu, L., Abshire, T.C., Homans, A., Billett, A.L., Yeager, A.M. and Findley, H.W. (2000) "Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia", Leukemia 14, 61-67.
  • Takemoto, S., Trovato, R., Cereseto, A., Nicot, C., Kislyakova, T., Casareto, L., Waldmann, T., Torelli, G. and Franchini, G. (2000) "p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(ARF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells", Blood 95, 3939-3944.
  • Plasschaert, S.L.A., Vellenga, E., De Bont, E.S.J.M., Van der Kolk, D.M., Veerman, A.J.P., De Vries, E.G.E. and Kamps, W.A. (2001) "High functional activity of P-glycoprotein is an independent prognostic factor for poor treatment outcome in T-cell acute lymphoblastic leukaemia", Leukemia 15, 501.
  • Gekeler, V., Frese, G., Noller, A., Handgretinger, R., Wilish, A., Schmidt, H., Muller, C.P., Dopfer, R., Klinebiel, T., Diddens, H., Probst, H. and Niethammer, D. (1992) "Mdr-1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukemias", British Journal of Cancer 66, 507-517.
  • Nooter, K. and Sonneveld, P. (1994) "Clinical relevance of P-glycoprotein expression in haematological malignancies", Leukemia Research 18, 233-243.
  • Jasmin, C., Charpentier, A., Marion, S. and Proctor, S.J. (1991) "Concepts of remission, curability and lineage involvement in relationship to the problems of minimal residual disease", Baillieres Clinical Haematology 4, 599-607.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.